Klus Pharma Inc. Report issue

For profit Phase 2
Founded: Monmouth Junction NJ United States (2014)

Organization Overview

First Clinical Trial
2018
NCT03602079
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Klus Pharma Inc.